Xiaoyan Wang Selected Research

Interleukin-6 (Interleukin 6)

1/2022	Exosomes from adipose-derived mesenchymal stem cells alleviate sepsis-induced lung injury in mice by inhibiting the secretion of IL-27 in macrophages.
11/2020	Investigation of the possible mechanism of two kinds of sterols extracted from Leucocalocybe mongolica in inducing HepG2 cell apoptosis and exerting anti-tumor effects in H22 tumor-bearing mice.
3/2017	Therapeutic effect of apocynin through antioxidant activity and suppression of apoptosis and inflammation after spinal cord injury.
1/2017	Murine Flt3 ligand-generated plasmacytoid and conventional dendritic cells display functional differentiation in activation, inflammation, and antigen presentation during BCG infection in vitro.
5/2016	PDCD4 Deficiency Aggravated Colitis and Colitis-associated Colorectal Cancer Via Promoting IL-6/STAT3 Pathway in Mice.
11/2011	IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyan Wang Research Topics

Disease

184	Neoplasms (Cancer) 12/2022 - 04/2002
43	Inflammation (Inflammations) 05/2022 - 01/2012
32	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2005
32	Hypertension (High Blood Pressure) 01/2020 - 04/2005
31	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2009
30	Infections 01/2022 - 01/2014
23	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2004
20	Fibrosis (Cirrhosis) 05/2022 - 02/2005
19	Carcinogenesis 12/2022 - 08/2010
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 07/2012
15	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2006
15	Hypoxia (Hypoxemia) 01/2022 - 01/2010
14	Colitis 04/2022 - 07/2013
12	Melanoma (Melanoma, Malignant) 07/2022 - 05/2013
12	Glioma (Gliomas) 04/2022 - 09/2008
11	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 05/2003
10	COVID-19 01/2022 - 01/2020
10	Myocardial Infarction 03/2021 - 09/2011
10	Atherosclerosis 01/2021 - 11/2010
9	Body Weight (Weight, Body) 05/2022 - 12/2012
9	Hemorrhage 05/2022 - 09/2010
9	Wounds and Injuries (Trauma) 01/2022 - 12/2013
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2014
9	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2011
9	Carcinoma (Carcinomatosis) 01/2021 - 05/2003
8	Ovarian Neoplasms (Ovarian Cancer) 02/2021 - 10/2010
7	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2013
7	Adenocarcinoma 01/2022 - 05/2011
7	Insulin Resistance 01/2021 - 01/2015
7	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 09/2008
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2022 - 12/2006
6	Ulcerative Colitis 01/2022 - 01/2016
6	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2021 - 11/2012
6	Diabetes Mellitus 01/2021 - 07/2007
6	Disease Progression 01/2019 - 04/2009
5	Rosacea (Acne Rosacea) 09/2022 - 08/2019
5	Ischemia 06/2022 - 01/2013
5	Burns 06/2022 - 02/2015
5	Infarction (Infarctions) 06/2022 - 01/2013
5	Osteosarcoma (Osteogenic Sarcoma) 03/2022 - 08/2011
5	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2016
5	Heart Failure 01/2022 - 05/2018
5	Necrosis 01/2022 - 03/2013

Drug/Important Bio-Agent (IBA)

83	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2004
33	Biomarkers (Surrogate Marker)IBA 03/2022 - 03/2007
31	CytokinesIBA 07/2022 - 04/2008
28	Pharmaceutical PreparationsIBA 12/2022 - 07/2007
22	Messenger RNA (mRNA)IBA 10/2022 - 09/2008
22	MicroRNAs (MicroRNA)IBA 12/2019 - 06/2013
19	Biological ProductsIBA 01/2022 - 05/2005
18	Long Noncoding RNAIBA 06/2022 - 07/2011
17	RNA (Ribonucleic Acid)IBA 07/2022 - 05/2013
15	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 01/2008
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2022 - 03/2009
12	VaccinesIBA 08/2021 - 01/2004
11	Phosphotransferases (Kinase)IBA 12/2022 - 07/2012
11	ErbB Receptors (EGF Receptor)IBA 01/2019 - 02/2007
11	SodiumIBA 04/2015 - 02/2005
10	EnzymesIBA 01/2022 - 02/2015
9	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 10/2010
9	LipopolysaccharidesIBA 01/2022 - 06/2016
9	LipidsIBA 10/2021 - 04/2009
9	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 02/2013
9	Peptides (Polypeptides)IBA 01/2021 - 02/2013
9	Dopamine Receptors (Dopamine Receptor)IBA 01/2015 - 04/2005
8	LigandsIBA 06/2022 - 01/2017
8	Hormones (Hormone)IBA 01/2022 - 10/2006
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2007
8	Insulin (Novolin)FDA Link 01/2021 - 01/2008
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 09/2011
7	CholesterolIBA 01/2022 - 01/2008
7	IronIBA 11/2021 - 01/2015
7	AntigensIBA 08/2021 - 01/2004
7	CollagenIBA 01/2021 - 07/2014
7	Amino Acids FDA Link 10/2020 - 04/2009
6	CateninsIBA 10/2022 - 10/2009
6	Oxygen (Dioxygen)IBA 06/2022 - 01/2010
6	Paclitaxel (Taxol)FDA LinkGeneric 06/2022 - 01/2004
6	Dextran SulfateIBA 04/2022 - 04/2019
6	Fluorescent Dyes (Fluorescent Probes)IBA 03/2022 - 01/2020
6	Therapeutic UsesIBA 03/2022 - 04/2009
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2011
6	Capsules (Microcapsules)IBA 01/2022 - 09/2010
6	Angiotensin IIIBA 01/2022 - 07/2008
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 05/2013
6	Estrogens (Estrogen)FDA Link 08/2019 - 09/2008
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2010
5	AntioxidantsIBA 07/2022 - 01/2017
5	AcidsIBA 05/2022 - 02/2010
5	HydrogelsIBA 01/2022 - 03/2017

Therapy/Procedure

96	Therapeutics 10/2022 - 05/2006
23	Drug Therapy (Chemotherapy) 10/2022 - 01/2004
17	Immunotherapy 01/2022 - 01/2004
14	Radiotherapy 01/2022 - 08/2006
11	Percutaneous Coronary Intervention 01/2022 - 07/2015
9	Transplantation 03/2021 - 08/2011
8	Length of Stay 05/2021 - 03/2014
7	Aftercare (After-Treatment) 05/2022 - 01/2008
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2021 - 05/2006
6	Stents 11/2019 - 03/2015